Lorven Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
- Satisfied Charges ₹ 1.89 Cr
- Revenue Growth -31.90%
- Profit Growth -143.84%
- Ebitda 12.22%
- Net Worth -9.03%
- Total Assets 0.17%
About Lorven Pharmaceuticals
Lorven Pharmaceuticals Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 March 2011 and has a history of 13 years and 11 months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Corporate was formerly known as Seagull Health Care Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹9.00 M. The company has closed loans amounting to ₹1.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Janardhan Ramamurthy, Govindaraajan Santhanakrishnan, and Govindaraajan Renuka serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U36912TN2011PTC079598
-
Company No.
079598
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Mar 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Lorven Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindaraajan Santhanakrishnan
|
Director | 01-Oct-2013 | Current |
|
Janardhan Ramamurthy
|
Director | 20-Feb-2012 | Current |
|
Govindaraajan Renuka
|
Director | 31-Mar-2014 | Current |
Financial Performance of Lorven Pharmaceuticals.
Lorven Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 31.9% decrease. The company also saw a substantial fall in profitability, with a 143.84% decrease in profit. The company's net worth dipped by a decrease of 9.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lorven Pharmaceuticals?
In 2022, Lorven Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lorven Metal Products Private LimitedGovindaraajan Santhanakrishnan and Govindaraajan Renuka are mutual person
Charges (Loans)
₹0.90 Cr
₹1.89 Cr
Charges Breakdown by Lending Institutions
- Others : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2019 | Others | ₹9.00 M | Open |
| 08 Jun 2016 | Tamilnad Mercantile Bank Limited | ₹9.13 M | Satisfied |
| 09 May 2015 | Tamilnad Mercantile Bank Limited | ₹9.75 M | Satisfied |
How Many Employees Work at Lorven Pharmaceuticals?
Unlock and access historical data on people associated with Lorven Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lorven Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lorven Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
